Literature DB >> 26607202

Platelet endothelial cell adhesion molecule-1 (PECAM1) plays a critical role in the maintenance of human vascular endothelial barrier function.

Qi Ren1,2, Limin Ren3, Changjie Ren2, Xuefei Liu1, Chun Dong2, Xinghua Zhang1.   

Abstract

Cardiovascular endothelial barrier dysfunction is associated with a number of cardiovascular diseases. This study aims to investigate the role of platelet endothelial cell adhesion molecule-1 (PECAM1) in the maintenance of the vascular endothelial barrier integrate. Human umbilical vein endothelial cells (HUVECs) were cultured into monolayers using as an in vitro model to assess the endothelial barrier function. Knockdown of the gene of PECAM1 markedly reduced the transendothelial resistance and increased the permeability of the HUVEC monolayers. From the wild HUVECs, we detected a complex of PECAM1, claudin1, occluding and endothelial cell selective adhesion molecule (ESAM); such a complex was not detected in the PECAM1-deficient HUVECs. Knockdown of either claudin1, or occludin, or ESAM, did not affect the formation of the tight junction (TJ) complex. Exposure to recombinant interleukin (IL)-13 inhibited the expression of PECAM1 and down-regulated the HUVEC monolayer barrier function. PECAM1 plays an important role in the formation of TJ complex.
Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  barrier function; endothelium; platelet endothelial cell adhesion molecule-1; tight junction; tight junction associated protein

Mesh:

Substances:

Year:  2015        PMID: 26607202     DOI: 10.1002/cbf.3155

Source DB:  PubMed          Journal:  Cell Biochem Funct        ISSN: 0263-6484            Impact factor:   3.685


  8 in total

1.  Flow cytometric characterization of the saphenous veins endothelial cells in patients with chronic venous disease and in patients undergoing bypass surgery: an exploratory study.

Authors:  Cláudia Torres; Rui Machado; Margarida Lima
Journal:  Heart Vessels       Date:  2019-06-21       Impact factor: 2.037

2.  A Fermented Whole Grain Prevents Lipopolysaccharides-Induced Dysfunction in Human Endothelial Progenitor Cells.

Authors:  Laura Giusti; Morena Gabriele; Giuseppe Penno; Monia Garofolo; Vincenzo Longo; Stefano Del Prato; Daniela Lucchesi; Laura Pucci
Journal:  Oxid Med Cell Longev       Date:  2017-03-13       Impact factor: 6.543

3.  The exosome of platelet endothelial cell adhesion molecule-1 (PECAM1) protein: A potential risking star in high blood pressure patients (HBPP).

Authors:  Zhidong Zhu; Yanyun Shen; Yunfeng Chen; Haiming Shi; Yun Shi
Journal:  Medicine (Baltimore)       Date:  2021-01-29       Impact factor: 1.817

4.  Network Pharmacology-Based Approach to Comparatively Predict the Active Ingredients and Molecular Targets of Compound Xueshuantong Capsule and Hexuemingmu Tablet in the Treatment of Proliferative Diabetic Retinopathy.

Authors:  Hongyan Yao; Danli Xin; Zongyi Zhan; Zijing Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-03-05       Impact factor: 2.629

5.  The Deletion of Endothelial Sodium Channel α (αENaC) Impairs Endothelium-Dependent Vasodilation and Endothelial Barrier Integrity in Endotoxemia in Vivo.

Authors:  Magdalena Sternak; Anna Bar; Mateusz G Adamski; Tasnim Mohaissen; Brygida Marczyk; Anna Kieronska; Marta Stojak; Kamil Kus; Antoine Tarjus; Frederic Jaisser; Stefan Chlopicki
Journal:  Front Pharmacol       Date:  2018-04-10       Impact factor: 5.810

6.  CD300A promotes tumor progression by PECAM1, ADCY7 and AKT pathway in acute myeloid leukemia.

Authors:  Xiaogang Sun; Shuhong Huang; Xin Wang; Xiaohua Zhang; Xin Wang
Journal:  Oncotarget       Date:  2018-01-11

7.  Effects of hub genes on the clinicopathological and prognostic features of lung adenocarcinoma.

Authors:  Dong-Hu Yu; Jing-Yu Huang; Xiao-Ping Liu; Xiao-Lan Ruan; Chen Chen; Wei-Dong Hu; Sheng Li
Journal:  Oncol Lett       Date:  2019-12-09       Impact factor: 2.967

8.  PECAM1, COL4A2, PHACTR1, and LMOD1 Gene Polymorphisms in Patients with Unstable Angina.

Authors:  Krzysztof Kosiński; Damian Malinowski; Krzysztof Safranow; Violetta Dziedziejko; Andrzej Pawlik
Journal:  J Clin Med       Date:  2022-01-13       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.